Overview
- Editors:
-
-
Brian Stabler
-
Department of Psychiatry School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA
-
Barry B. Bercu
-
Department of Pediatrics College of Medicine, University of South Florida, All Children’s Hospital, St. Petersburg, USA
Access this book
Other ways to access
Table of contents (23 papers)
-
-
Outcome Research in Pediatric Psychoendocrinology and Sexology
-
-
Treatment of Growth Hormone Deficiency: Efficacy, Innovation and Quality of Life
-
-
- Paul V. Carroll, Emanuel R. Christ, Peter H. Sönksen
Pages 9-20
-
- Ingela K. Wiklund, Ann E. Erling, Kerstin Albertsson-Wikland
Pages 21-29
-
-
- David E. Sandberg, Margaret H. MacGillivray, Richard R. Clopper, Dana E. Alliger, Caroline Fung, Linda LeRoux
Pages 38-52
-
- Ana Claudia Keselman, Alicia Susana MartĂnez, Liliana Pantano, CĂ©sar Bergadá, Juan Jorge Heinrich
Pages 53-60
-
Treatment of Turner Syndrome: Efficacy, Innovation and Quality of Life
-
-
-
- David Skuse, Dorothy Bishop, Kate Elgar, Elena Morris
Pages 69-82
-
- Margaret H. MacGillivray, Tom Mazur
Pages 83-97
-
Treatment of Short, Non-Growth Hormone Deficiency: Efficacy, Innovation and Quality of Life
-
-
- Louis E. Underwood, Brian Stabler
Pages 101-109
-
- Dennis Drotar, Jane R. Robinson
Pages 110-118
-
- Jessica C. Roberts, Martha U. Barnard, Michael C. Roberts, Wayne V. Moore, Eric M. Vernberg, Jerome A. Grunt et al.
Pages 119-130
-
- Ulla Wide Boman, Kerstin Albertsson-Wikland, Anders Möller
Pages 131-136
-
Treatment of Diabetes: Efficacy, Innovation and Quality of Life
-
Front Matter
Pages 137-137
-
-
About this book
Changes in the allocation of healthcare resources have raised issues related to the efficacy and outcomes of medical therapy and how such factors may be measured. The questions associated with the quality of life and functional capability of patients with chronic health conditions have been of special interest. Endocrine disorders have the potential for disrupting the general health and well-being of affected individuals and their families; thus they warrant serious attention. This symposium was convened in November 1997 at Palm Beach Gardens, Florida, to bring together medical, behavioral, and social scientists. The meeting fostered the presentation and discussion of the most current clinical research on the effects of various therapies on a wide range of endocrine disorders from diabetes to adrenal insufficiency and growth hormone deficiency. The participants, all noted national and international experts in their fields, focused their attention on both the biomedical value and effectiveness of treatment, as well as on the impact such treatments have on psychological states such as mood and cognition. Many presentations specifically emphasized the quality of life (QOL) indicators that now regu larly appear in many research protocols and reports. The pioneering work of two clinical researchers was a major highlight of the meeting and an Award of Recognition was presented to Robert Blizzard, M. D. , and John Money, Ph. D. , for their innovative and insightful work in pediatric endocrinology and psychosexual development.
Editors and Affiliations
-
Department of Psychiatry School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, USA
Brian Stabler
-
Department of Pediatrics College of Medicine, University of South Florida, All Children’s Hospital, St. Petersburg, USA
Barry B. Bercu
